Follow-up studies from CBCS found associations between higher expression of PSPH and risk of recurrence (HR 1.76, 95% CI 1.15–2.68) [37] and that both CRYBB2 and CRYBB2P1 promote tumor progression in vivo [38]. This evidence concerns the gene CRYBB2P1 and neoplasm.